Bioharvest Sciences (BHST) Cash from Financing Activities (2023 - 2025)

Bioharvest Sciences' Cash from Financing Activities history runs 3 years deep, the most recent figure standing at $14.9 million for Q4 2025.

• In Q4 2025, Cash from Financing Activities rose 508.92% year-over-year to $14.9 million; the TTM figure through Dec 2025 stood at $30.2 million (up 345.24% YoY), while the FY2025 annual figure was $30.2 million, up 345.24% from the prior year.
• Cash from Financing Activities was $14.9 million for Q4 2025 at Bioharvest Sciences, up from $9.7 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $14.9 million in Q4 2025 to a low of -$164000.0 in Q3 2024.
• Historically, Cash from Financing Activities has averaged $4.5 million across 3 years, with a median of $2.8 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities slumped 113.86% in 2024, then soared 6036.59% in 2025.
• A 3-year view of Cash from Financing Activities shows it stood at $7.0 million in 2023, then slumped by 64.99% to $2.5 million in 2024, then surged by 508.92% to $14.9 million in 2025.
• The last three Cash from Financing Activities figures came in at $14.9 million (Q4 2025), $9.7 million (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.